Skip to main content
    P

    ProKidney Corp. (PROK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.10
    +0.06 (+5.77%)

    Market Cap: $417.20M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    ProKidney Corp. (PROK) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    ProKidney (PROK) has a market cap of $417.20M and an enterprise value of $337.99M. It kept -23445.42% of revenue as net income over the last 12 months. Its share count is up 53.90% from a year earlier.

    Total Valuation

    Enterprise value is 18.99% below the market cap, as cash exceeds debt.

    Market Cap$417.20M
    Enterprise Value$337.99M
    Latest price (Nov 17, 2026)$1.10

    Key Dates

    The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 16, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 11.36% in the quarter ended Sep 30, 2026 and grew 28.32% a year over 2 years.

    Shares Outstanding207.76M
    Shares Change (YoY)+53.90%
    Shares Change (QoQ)+11.36%
    Share Count Growth (2Y CAGR)+28.32%

    Valuation Ratios

    The price to sales ratio is 294.9x.

    P/S Ratio294.9x
    Forward P/S562.8x

    Price Statistics

    The stock is down 54.36% over 52 weeks and trades 26.17% below its 50-day average.

    Beta (1Y)1.77
    52-Week Change-54.36%
    1-Month Change-21.15%
    3-Month Change-25.68%
    6-Month Change-29.03%
    Total Return (1Y)-54.36%
    Total Return (3Y CAGR)-3.13%
    Return vs SPY (1Y)-63.31%
    Max Drawdown (1Y)-59.53%
    Max Drawdown (3Y)-87.84%
    Sharpe Ratio (1Y)-1.00
    Correlation with SPY (1Y)0.33
    50-Day Average$1.49
    200-Day Average$1.76
    52-Week Range$0.87 to $2.65
    RSI (14 Days)38.2
    Average Volume (20 Days)1.41M

    Price chart

    Financial Position

    Current assets cover 5.04x current liabilities.

    Current Ratio5.04x
    Quick Ratio5.04x
    Interest Coverage-10690.83x

    Returns and Efficiency

    Return on invested capital is 21.04% over the last 12 months, against a 5-year average of 16.32%.

    Return on Assets (ROA)-86.41%
    Return on Invested Capital (ROIC)21.04%
    ROA (5Y Average)-55.97%
    ROIC (5Y Average)16.32%
    Asset Turnover0.00x

    Scores

    PROK has an Altman Z-Score of -7.22, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-7.22
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $775.00K over the last 12 months is up 4.17% from the 12 months before.

    Revenue$775.00K
    Revenue Growth (YoY)+4.17%
    Gross Profit$775.00K
    Operating Income-$192.44M
    Pretax Income-$183.72M
    Net Income-$181.70M
    Reported EPS (TTM)-$0.60

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$81.36M
    Total Debt$2.14M
    Net Cash$79.21M
    Net Cash Per Share$0.38
    Working Capital$121.41M
    Shareholder Equity-$906.85M
    Total Assets$210.28M
    Total Liabilities$33.30M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $14.60M of capital spending, operating cash flow left -$167.83M of free cash flow.

    Operating Cash Flow-$153.22M
    Capital Expenditures$14.60M
    Free Cash Flow-$167.83M
    FCF Per Share-$0.80
    Depreciation and Amortization$6.85M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -24830.32%.

    Gross Margin100.00%
    Operating Margin-24830.32%
    Pretax Margin-23706.19%
    Net Margin-23445.42%
    FCF Margin-21654.97%

    Dividends and Yields

    PROK does not pay a dividend. Its free cash flow yield is -73.44%.

    FCF Yield-73.44%
    Buyback Yield-7.51%
    Shareholder Yield-7.51%

    Peer Position

    Against 7 similar companies, PROK has the highest P/S.

    P/S Ratio294.9x vs 1.7x median
    ROIC21.04% vs -4.39% median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.17% vs +17.57% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -16.02% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-16.02%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PROK

    What is PROK's market cap?

    ProKidney has a market cap of $417.20M. Its enterprise value, which adds debt and subtracts cash, is $337.99M.

    How many shares of PROK are outstanding?

    ProKidney has 207.76M shares outstanding. The count is up 53.90% from a year earlier.

    Does PROK pay a dividend?

    No. ProKidney does not pay a dividend.

    How much debt does PROK have?

    ProKidney has $2.14M of total debt and $81.36M of cash and equivalents, a net cash position of $79.21M.